PL376607A1 - Application of antagonists oxytocin and/or vasopressin - Google Patents
Application of antagonists oxytocin and/or vasopressinInfo
- Publication number
- PL376607A1 PL376607A1 PL376607A PL37660705A PL376607A1 PL 376607 A1 PL376607 A1 PL 376607A1 PL 376607 A PL376607 A PL 376607A PL 37660705 A PL37660705 A PL 37660705A PL 376607 A1 PL376607 A1 PL 376607A1
- Authority
- PL
- Poland
- Prior art keywords
- oxytocin
- vasopressin
- antagonists
- application
- antagonists oxytocin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Priority Applications (21)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL376607A PL376607A1 (en) | 2005-08-12 | 2005-08-12 | Application of antagonists oxytocin and/or vasopressin |
PT06747719T PT1879572E (en) | 2005-05-10 | 2006-05-10 | Use of antagonists of oxytocin and/or vasopressin in assisted reproduction |
AT06747719T ATE507830T1 (en) | 2005-05-10 | 2006-05-10 | USE OF ANTAGONISTS OF OXYTOCIN AND/OR VASOPRESSIN IN ASSISTED REPRODUCTION |
PCT/PL2006/000029 WO2006121362A2 (en) | 2005-05-10 | 2006-05-10 | Use of antagonists of oxytocin and/or vasopressin in assisted reproduction |
CN2006800568367A CN101646436B (en) | 2005-05-10 | 2006-05-10 | Use of antagonists of oxytocin and/or vasopressin in assisted reproductive technology |
MX2007014022A MX2007014022A (en) | 2005-05-10 | 2006-05-10 | Use of antagonists of oxytocin and/or vasopressin in assisted reproduction. |
RU2007140702/15A RU2385735C2 (en) | 2005-05-10 | 2006-05-10 | Application of oxytocin antagonists in assisted reproduction |
DE602006021736T DE602006021736D1 (en) | 2005-05-10 | 2006-05-10 | USE OF ANTAGONISTS OF OXYTOCIN AND / OR VASOPRESSIN IN ASSISTED REPRODUCTION |
PL06747719T PL1879572T3 (en) | 2005-05-10 | 2006-05-10 | Use of antagonists of oxytocin and/or vasopressin in assisted reproduction |
CA2605923A CA2605923C (en) | 2005-05-10 | 2006-05-10 | Use of antagonists of oxytocin and/or vasopressin |
NZ562409A NZ562409A (en) | 2005-05-10 | 2006-05-10 | Use of barusiban in assisted reproduction |
KR1020077025706A KR100985449B1 (en) | 2005-05-10 | 2006-05-10 | Use of antagonists of oxytocin and/or vasopressin in assisted reproduction |
DK06747719.0T DK1879572T3 (en) | 2005-05-10 | 2006-05-10 | Use of antagonists of oxytocin and / or vasopressin in artificial insemination |
ES06747719T ES2366130T3 (en) | 2005-05-10 | 2006-05-10 | USE OF OXYCHOCINE AND / OR VASOPRESINE ANTAGONISTS IN ASSISTED REPRODUCTION. |
US11/914,049 US20080318847A1 (en) | 2005-05-10 | 2006-05-10 | Use of Antagonist of Oxytocin and/or Vasopressin in Assisted Reproduction |
JP2008511075A JP4762308B2 (en) | 2005-05-10 | 2006-05-10 | Use of oxytocin and / or vasopressin antagonists in assisted reproduction |
AU2006244693A AU2006244693B2 (en) | 2005-05-10 | 2006-05-10 | Use of antagonists of oxytocin and/or vasopressin in assisted reproduction |
SI200631039T SI1879572T1 (en) | 2005-05-10 | 2006-05-10 | Use of antagonists of oxytocin and/or vasopressin in assisted reproduction |
EP06747719A EP1879572B1 (en) | 2005-05-10 | 2006-05-10 | Use of antagonists of oxytocin and/or vasopressin in assisted reproduction |
IL186595A IL186595A (en) | 2005-05-10 | 2007-10-11 | Use of barusiban for the preparation of medicaments for an improved uterine receptivity in assisted reproduction |
NO20076328A NO340956B1 (en) | 2005-05-10 | 2007-12-10 | Use of antagonists for oxytocin and / or vasopressin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL376607A PL376607A1 (en) | 2005-08-12 | 2005-08-12 | Application of antagonists oxytocin and/or vasopressin |
Publications (1)
Publication Number | Publication Date |
---|---|
PL376607A1 true PL376607A1 (en) | 2007-02-19 |
Family
ID=43013708
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL376607A PL376607A1 (en) | 2005-05-10 | 2005-08-12 | Application of antagonists oxytocin and/or vasopressin |
Country Status (1)
Country | Link |
---|---|
PL (1) | PL376607A1 (en) |
-
2005
- 2005-08-12 PL PL376607A patent/PL376607A1/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL185343A0 (en) | 2-(4-oxo-4h-quinazolin-3-yl)acetamides and their use as vasopressin v3 antagonists | |
EP1952334A4 (en) | Detection of intra-firm matching and response thereto | |
EP1812030A4 (en) | Anti-angiogenic peptides and methods of use thereof | |
EP1786451A4 (en) | Anti-angiogenic peptides and methods of use thereof | |
PL2027096T3 (en) | Substituted arylimidaz0l0ne and triaz0l0ne as inhibitors of vasopressin receptors | |
EP1976864A4 (en) | Novel peptide and use thereof | |
HK1144373A1 (en) | Use of fungal immunomodulatory protein | |
IL190217A0 (en) | Combination of rosiglitazone and donepezil for improvement of cognitive function | |
IL185309A0 (en) | Isoqunoline compounds and methods of use thereof | |
IS8248A (en) | Replacement of tweketopiperazine and its use as oxytocin antagonists | |
IL182494A0 (en) | Non-peptide bradykinin antagonists and pharmaceutical composition therefrom | |
EP1928496A4 (en) | C/clp antagonists and methods of use thereof | |
PT2380573E (en) | Eslicarbazepine acetate and methods of use | |
GB0505975D0 (en) | Novel use of peptide | |
HK1161122A1 (en) | Use of 24-norudca 24-norudca | |
EP1921066A4 (en) | Pyridylphenol compound and use thereof | |
EP1931368A4 (en) | Antifungal peptides and methods of use thereof | |
EP1967210A4 (en) | Novel application of apelin | |
PL379702A1 (en) | Benzamide derivatives as oxytocin agonists and vasopressin antagonists | |
ZA200707090B (en) | 2-(4-oxo-4H-quinazolin-3-yl) acetamides and their use as vasopressin V3 antagonists | |
EP1931370A4 (en) | Use of des-aspartate-angiotensin i | |
PL376607A1 (en) | Application of antagonists oxytocin and/or vasopressin | |
ZA200802439B (en) | Combination of rosiglitazone and donepezil for improvement of cognitive function | |
ZA200805245B (en) | Combination of AXD2171 and pemetrexed | |
EP1805512A4 (en) | Detection of bromamines and chloramines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |